[1]Younossi Z, Tacke F, Arrese M, Chander Sharma B, Mostafa I, Bugianesi E, et al. Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Hepatology. 2019;69(6):2672-82.[ 10.1002/hep.30251][PMID]

[2]Grissa D, Nytoft Rasmussen D, Krag A, Brunak S, Juhl Jensen L. Alcoholic liver disease: A registry view on comorbidities and disease prediction. PLoS Comput Biol. 2020;16(9):e1008244.[ 10.1371/journal.pcbi.1008244][PMID]

[3]Lee JS, Kim ES, Moon WJCe. Chronological review of endoscopic indices in inflammatory bowel disease. 2019;52(2):129-36[10.5946/ce.2018.042][PMID]

[4]Lupsor-Platon M, Serban T, Silion AI, Tirpe GR, Tirpe A, Florea M. Performance of Ultrasound Techniques and the Potential of Artificial Intelligence in the Evaluation of Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease. Cancers (Basel). 2021;13(4):790.[ 10.3390/cancers13040790][ PMID]

[5]Zhang L, Mao Y, editors. Artificial intelligence in NAFLD: will liver biopsy still be necessary in the future? Healthcare; 2022: MDPI.[ 10.3390/healthcare11010117][PMID]

[6]Zhou J, Du M, Chang S, Chen Z. Artificial intelligence in echocardiography: detection, functional evaluation, and disease diagnosis. Cardiovasc Ultrasound. 2021;19(1):29.[10.1186/s12947-021-00261-2][PMID]

[7]Tran KA, Kondrashova O, Bradley A, Williams ED, Pearson JV, Waddell N. Deep learning in cancer diagnosis, prognosis and treatment selection. Genome Med. 2021;13(1):152.[ 10.1186/s13073-021-00968-x][PMID]

[8]Reddy KVV, Elamvazuthi I, Abd Aziz A, Paramasivam S, Chua HN, Pranavanand S, editors. Rotation forest ensemble classifier to improve the cardiovascular disease risk prediction accuracy. 2021 8th NAFOSTED Conference on Information and Computer Science (NICS); 2021: IEEE. [10.1109/NICS54270.2021.9701455]

[9]Gurupur VP, Kulkarni SA, Liu X, Desai U, Nasir AJJoE, Intelligence TA. Analysing the power of deep learning techniques over the traditional methods using medicare utilisation and provider data. 2018;31:115 - 99[10.1080/0952813X.2018.1518999]

[10]Ojha AKJJoAI, Machine Learning, Network N. AI-Augmented Fault Detection and Diagnosis in VLSI Circuits: A Step toward Intelligent Chip Design. 2024[10.55529/jaimlnn.46.39.46]

[11]Goshayeshi L, Hoseini B, Yousefli Z, Khooie A, Etminani K, Esmaeilzadeh A, et al. Predictive model for survival in patients with gastric cancer. Electron Physician. 2017;9(12):6035-42.[ 10.19082/6035] [PMID]

[12]Sabetian G, Azimi A, Kazemi A, Hoseini B, Asmarian N, Khaloo V, et al. Prediction of Patients with COVID-19 Requiring Intensive Care: A Cross-sectional Study Based on Machine-learning Approach from Iran. Indian J Crit Care Med. 2022;26(6):688-95.[ 10.5005/jp-journals-10071-24226] [PMID]

[13]Tolstyak Y, Zhuk R, Yakovlev I, Shakhovska N, Gregus ml M, Chopyak V, et al. The ensembles of machine learning methods for survival predicting after kidney transplantation. 2021;11(21):10380[10.3390/app112110380]

[14]Saberi-Karimian M, Khorasanchi Z, Ghazizadeh H, Tayefi M, Saffar S, Ferns GA, et al. Potential value and impact of data mining and machine learning in clinical diagnostics. Crit Rev Clin Lab Sci. 2021;58(4):275-96.[ 10.1080/10408363.2020.1857681] [PMID]

[15]Cao LL, Peng M, Xie X, Chen GQ, Huang SY, Wang JY, et al. Artificial intelligence in liver ultrasound. World J Gastroenterol. 2022;28(27):3398-409.[ 10.3748/wjg.v28.i27.3398] [PMID]

[16]          Lu F, Meng Y, Song X, Li X, Liu Z, Gu C, et al. Artificial Intelligence in Liver Diseases: Recent Advances. Adv Ther. 2024;41(3):967-90.[10.1007/s12325-024-02781-5] [PMID]

[17]Nishida N, Kudo M. Artificial intelligence models for the diagnosis and management of liver diseases. Ultrasonography. 2023;42(1):10-9.[ 10.14366/usg.22110]

[18]Mahzari AJELJ. Artificial intelligence in nonalcoholic fatty liver disease. 2022;12(1):69[10.1186/s43066-022-00224-w]

[19]Alqahtani SA, Schattenberg JM. Nonalcoholic fatty liver disease: use of diagnostic biomarkers and modalities in clinical practice. Expert Rev Mol Diagn. 2021;21(10):1065-78.[10.1080/14737159.2021.1964958] [PMID]

[20]          Bharti P, Mittal D, Ananthasivan R. Computer-aided Characterization and Diagnosis of Diffuse Liver Diseases Based on Ultrasound Imaging: A Review. Ultrason Imaging. 2017;39(1):33-61.[10.1177/0161734616639875] [PMID]

• Grissa D, Nytoft Rasmussen D, Krag A, Brunak S, Juhl Jensen L. Alcoholic liver disease: A registry view on comorbidities and disease prediction. PLoS Computational Biology. 2020 Sep 22;16(9):e1008244. [1371/journal.pcbi.1008244 ] [PMID]
• Kim T, Lee DH, Park EK, Choi S. Deep learning techniques for fatty liver using multi-view ultrasound images scanned by different scanners: Development and validation study. JMIR Medical Informatics. 2021 Nov 18;9(11):e30066. [2196/30066 ] [PMID]
• Yang Y, Liu J, Sun C, Shi Y, Hsing JC, Kamya A, Keller CA, Antil N, Rubin D, Wang H, Ying H. Nonalcoholic fatty liver disease (NAFLD) detection and deep learning in a Chinese community-based population. European Radiology. 2023 Aug;33(8):5894-906. [1007/s00330-023-09515-1 ] [PMID]
• Zhang D, Zhang XY, Duan YY, Dietrich CF, Cui XW, Zhang CX. An overview of ultrasound-derived radiomics and deep learning in liver. Medical Ultrasonography. 2023 Dec 27;25(4):445-52. [11152/mu-4080 ] [PMID]
• Sowa J-P, Heider D, Bechmann LP, Gerken G, Hoffmann D, Canbay AJPo. Novel algorithm for non-invasive assessment of fibrosis in NAFLD. 2013;8(4):e62439. [1371/journal.pone.0062439 ] [PMID]
• Yang A, Zhu X, Zhang L, Zhang Y, Zhang D, Jin M, et al. Non-invasive evaluation of NAFLD and the contribution of genes: an MRI-PDFF-based cross-sectional study. 2022;16(5):1035-51. [1007/s12072-022-10355-2 ] [PMID]
• Zhang L, Huang Y, Huang M, Zhao CH, Zhang YJ, Wang Y. Development of cost-effective fatty liver disease prediction models in a chinese population: statistical and machine learning approaches. JMIR Formative Research. 2024 Feb 16;8:e53654. [2196/53654 ] [PMID]
• Makkena KR, Natarajan K. Classification algorithms for liver epidemic identification. EAI Endorsed Trans. Perv. Health Tech. 2023;9:1-3.
• Owjimehr M, Danyali H, Helfroush MSJJoMS, Sensors. An improved method for liver diseases detection by ultrasound image analysis. 2015;5(1):21-9. [PMID]
• Wu CT, Chu TW, Jang JS. Current-Visit and Next-Visit Prediction for Fatty Liver Disease With a Large-Scale Dataset: Model Development and Performance Comparison. JMIR Medical Informatics. 2021 Aug 12;9(8):e26398. [2196/26398 ] [PMID]
• Feng G, Zheng KI, Li YY, Rios RS, Zhu PW, Pan XY, Li G, Ma HL, Tang LJ, Byrne CD, Targher G. Machine learning algorithm outperforms fibrosis markers in predicting significant fibrosis in biopsy‐confirmed NAFLD. Journal of Hepato‐Biliary‐Pancreatic Sciences. 2021 Jul;28(7):593-603.[ 1002/jhbp.972 ] [PMID]
• Nagy G, Munteanu M, Gordan M, Chira R, Iancu M, Crisan D, Mircea PA. Computerized ultrasound image analysis for noninvasive evaluation of hepatic steatosis. Medical ultrasonography. 2015 Dec 1;17(4):431-6. .[ 11152/mu.2013.2066.174.cmu ] [PMID]
• Zhu Q, Li H, Ao Z, Xu H, Luo J, Kaurich C, Yang R, Zhu PW, Chen SD, Wang XD, Tang LJ. Lipidomic identification of urinary extracellular vesicles for non-alcoholic steatohepatitis diagnosis. Journal of Nanobiotechnology. 2022 Jul 27;20(1):349. .[ 1186/s12951-022-01540-4 ] [PMID]
• Li G, Zheng TL, Chi XL, Zhu YF, Chen JJ, Xu L, Shi JP, Wang XD, Zhao WG, Byrne CD, Targher G. LEARN algorithm: a novel option for predicting non-alcoholic steatohepatitis. Hepatobiliary Surgery and Nutrition. 2023 Mar 30;12(4):507. .[ 21037/hbsn-21-523 ] [PMID]
• Yang T, Zhao B, Pei DJD, Metabolic Syndrome, Obesity. Estimation of the prevalence of nonalcoholic fatty liver disease in an adult population in Northern China using the data mining approach. 2021:3437-45. .[ 2147/DMSO.S320808 ] [PMID]
• Wang RR, Chen JL, Duan SJ, Lu YX, Chen P, Zhou YC, Yao SK. Noninvasive Diagnostic Technique for Nonalcoholic Fatty Liver Disease Based on Features of Tongue Images. Chinese journal of integrative medicine. 2024 Mar;30(3):203-12. .[ 1007/s11655-023-3616-1 ] [PMID]
• Chae W, Lee KJ, Huh KY, Moon JS, Ko JS, Cho JY. Association of Metabolic Signatures with Nonalcoholic Fatty Liver Disease in Pediatric Population. Metabolites. 2022 Sep 19;12(9):881. .[ 3390/metabo12090881 ] [PMID]
• Docherty M, Regnier SA, Capkun G, Balp MM, Ye Q, Janssens N, Tietz A, Löffler J, Cai J, Pedrosa MC, Schattenberg JM. Development of a novel machine learning model to predict presence of nonalcoholic steatohepatitis. Journal of the American Medical Informatics Association. 2021 Jun 1;28(6):1235-41. .[ 1093/jamia/ocab003 ] [PMID]
• Arzehgar A, Nezhad Noor Nia RG, Dehdeleh V, Roudi F, Eslami S. Non-Alcoholic Fatty Liver Disease Diagnosis with Multi-Group Factors. InHealthcare Transformation with Informatics and Artificial Intelligence 2023 (pp. 503-506). IOS Press. .[ 3233/SHTI230543 ] [PMID]
• Ma X, Yang C, Liang K, Sun B, Jin W, Chen L, Dong M, Liu S, Xin Y, Zhuang L. A predictive model for the diagnosis of non-alcoholic fatty liver disease based on an integrated machine learning method. American Journal of Translational Research. 2021 Nov 15;13(11):12704. [PMID]
• Das A, Connell M, Khetarpal S. Digital image analysis of ultrasound images using machine learning to diagnose pediatric nonalcoholic fatty liver disease. Clinical imaging. 2021 Sep 1;77:62-8. [1016/j.clinimag.2021.02.038 ] [PMID]
• Shahabi M, Hassanpour H, Mashayekhi H. Rule extraction for fatty liver detection using neural networks. Neural Computing and Applications. 2019 Apr 1;31:979-89.
• Jiang T, Guo XJ, Tu LP, Lu Z, Cui J, Ma XX, Hu XJ, Yao XH, Cui LT, Li YZ, Huang JB. Application of computer tongue image analysis technology in the diagnosis of NAFLD. Computers in Biology and Medicine. 2021 Aug 1;135:104622. [1016/j.compbiomed.2021.104622 ] [PMID]
• Jeon SK, Lee JM, Joo I, Yoon JH, Lee G. Two-dimensional convolutional neural network using quantitative US for noninvasive assessment of hepatic steatosis in NAFLD. Radiology. 2023 Jan 3;307(1):e221510. [1148/radiol.221510 ] [PMID]
• Ghandian S, Thapa R, Garikipati A, Barnes G, Green‐Saxena A, Calvert J, Mao Q, Das R. Machine learning to predict progression of non‐alcoholic fatty liver to non‐alcoholic steatohepatitis or fibrosis. JGH Open. 2022 Mar;6(3):196-204. [1002/jgh3.12716 ] [PMID]
• McTeer M, Applegate D, Mesenbrink P, Ratziu V, Schattenberg JM, Bugianesi E, Geier A, Romero Gomez M, Dufour JF, Ekstedt M, Francque S. Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical information. Plos one. 2024 Feb 29;19(2):e0299487. [1371/journal.pone.0299487 ] [PMID]
• Han N, He J, Shi L, Zhang M, Zheng J, Fan Y. Identification of biomarkers in nonalcoholic fatty liver disease: a machine learning method and experimental study. Frontiers in Genetics. 2022 Nov 7;13:1020899. [3389/fgene.2022.1020899 ] [PMID]
• Douali N. Nonalcoholic Steatohepatitis Diagnosis–A Model-Related Personalized Medicine Approach. InpHealth 2022 2022 (pp. 191-195). IOS Press. [3233/SHTI220982 ] [PMID]
• Cheung JT, Zhang X, Wong GL, Yip TC, Lin H, Li G, Leung HH, Lai JC, Mahadeva S, Nik Mustapha NR, Wang XD. MAFLD fibrosis score: using routine measures to identify advanced fibrosis in metabolic‐associated fatty liver disease. Alimentary Pharmacology & Therapeutics. 2023 Dec;58(11-12):1194-204. [1111/apt.17722 ] [PMID]
• Verma N, Duseja A, Mehta M, De A, Lin H, Wong VW, Wong GL, Rajaram RB, Chan WK, Mahadeva S, Zheng MH. Machine learning improves the prediction of significant fibrosis in Asian patients with metabolic dysfunction‐associated steatotic liver disease–The Gut and Obesity in Asia (GO‐ASIA) Study. Alimentary Pharmacology & Therapeutics. 2024 Mar;59(6):774-88. [1111/apt.17891 ] [PMID]
• Su TH, Wu CH, Kao JH. Artificial intelligence in precision medicine in hepatology. Journal of Gastroenterology and Hepatology. 2021 Mar;36(3):569-80. [1111/jgh.15415 ] [PMID]
• Subramanya MB, Kumar V, Mukherjee S, Saini M. A CAD system for B-mode fatty liver ultrasound images using texture features. Journal of medical engineering & technology. 2015 Feb 17;39(2):123-30. [3109/03091902.2014.990160 ] [PMID]
• Alici-Karaca D, Akay B, Yay A, Suna P, Nalbantoglu OU, Karaboga D, Basturk A, Balcioglu E, Baran M. A new lightweight convolutional neural network for radiation-induced liver disease classification. Biomedical Signal Processing and Control. 2022 Mar 1;73:103463.
• Pei X, Deng Q, Liu Z, Yan X, Sun WJAoN, Metabolism. Machine learning algorithms for predicting fatty liver disease. 2021;77(1):38-45. [1159/000513654 ] [PMID]
• Chiappini F, Coilly A, Kadar H, Gual P, Tran A, Desterke C, Samuel D, Duclos-Vallée JC, Touboul D, Bertrand-Michel J, Brunelle A. Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients. Scientific reports. 2017 Apr 24;7(1):46658. [1038/srep46658 ] [PMID]
• Jiang T, Lu Z, Hu X, Zeng L, Ma X, Huang J, Cui J, Tu L, Zhou C, Yao X, Xu J. Deep learning multi‐label tongue image analysis and its application in a population undergoing routine medical checkup. Evidence‐Based Complementary and Alternative Medicine. 2022;2022(1):3384209. [1155/2022/3384209 ] [PMID]
• Zamanian H, Shalbaf A. Estimation of non-alcoholic steatohepatitis (NASH) disease using clinical information based on the optimal combination of intelligent algorithms for feature selection and classification. Computer Methods in Biomechanics and Biomedical Engineering. 2024 Jun 10;27(8):964-79. [1080/10255842.2023.2217978 ] [PMID]
• Douali N, Abdennour M, Sasso M, Miette V, Tordjman J, Bedossa P, Veyrie N, Poitou C, Aron-Wisnewsky J, Clément K, Jaulent MC. Noninvasive diagnosis of nonalcoholic steatohepatitis disease based on clinical decision support system. InMEDINFO 2013 2013 (pp. 1178-1178). IOS Press. [PMID]
• Minhas FU, Sabih D, Hussain M. Automated classification of liver disorders using ultrasound images. Journal of medical systems. 2012 Oct;36:3163-72. [1007/s10916-011-9803-1 ] [PMID]
• Wagner J, Kumar Y, Lautenbach A, von Kroge P, Wolter S, Mann O, Izbicki J, Gagliani N, Duprée A. Fatty acid-binding protein-4 (FABP4) and matrix metalloproteinase-9 (MMP9) as predictive values for nonalcoholic steatohepatitis (NASH). Lipids in Health and Disease. 2023 Jan 6;22(1):1. [1186/s12944-022-01764-1 ] [PMID]
• Gaber A, Youness HA, Hamdy A, Abdelaal HM, Hassan AM. Automatic classification of fatty liver disease based on supervised learning and genetic algorithm. Applied Sciences. 2022 Jan 5;12(1):521.
• Lusnig L, Sagingalieva A, Surmach M, Protasevich T, Michiu O, McLoughlin J, Mansell C, de’Petris G, Bonazza D, Zanconati F, Melnikov A. Hybrid quantum image classification and federated learning for hepatic steatosis diagnosis. Diagnostics. 2024 Mar 6;14(5):558. [3390/diagnostics14050558 ] [PMID]
• Zhao M, Song C, Luo T, Huang T, Lin S. Fatty liver disease prediction model based on big data of electronic physical examination records. Frontiers in public health. 2021 Apr 12;9:668351. [3389/fpubh.2021.668351 ] [PMID]
• Ülger Y, Delik A. Artificial intelligence model with deep learning in nonalcoholic fatty liver disease diagnosis: Genetic based artificial neural networks. Nucleosides, Nucleotides & Nucleic Acids. 2023 May 4;42(5):398-406. [1080/15257770.2022.2152046 ] [PMID]
• Sorino P, Campanella A, Bonfiglio C, Mirizzi A, Franco I, Bianco A, Caruso MG, Misciagna G, Aballay LR, Buongiorno C, Liuzzi R. Development and validation of a neural network for NAFLD diagnosis. Scientific Reports. 2021 Oct 12;11(1):20240. [1038/s41598-021-99400-y ] [PMID]
• Xiao W, Huang X, Wang JH, Lin DR, Zhu Y, Chen C, Yang YH, Xiao J, Zhao LQ, Li JP, Cheung CY. Screening and identifying hepatobiliary diseases through deep learning using ocular images: a prospective, multicentre study. The Lancet Digital Health. 2021 Feb 1;3(2):e88-97. [1016/S2589-7500(20)30288-0 ] [PMID]
• Sripongpun P, Kim WR, Mannalithara A, Charu V, Vidovszky A, Asch S, Desai M, Kim SH, Kwong AJ. The steatosis‐associated fibrosis estimator (SAFE) score: a tool to detect low‐risk NAFLD in primary care. Hepatology. 2023 Jan 1;77(1):256-67. [1002/hep.32545 ] [PMID]
• Wang Q, Lai MW, Bin G, Ding Q, Wu S, Zhou Z, Tsui PH. MBR-Net: A multi-branch residual network based on ultrasound backscattered signals for characterizing pediatric hepatic steatosis. Ultrasonics. 2023 Dec 1;135:107093. [1016/j.ultras.2023.107093 ] [PMID]
• Huang H, Liu Y, Xiong Q, Xing Y, Du H. A fatty liver diseases classification network based on adaptive coordination attention with label smoothing. Biomedical Signal Processing and Control. 2023 Sep 1;86:105267.
• Guarneros-Nolasco LR, Alor-Hernández G, Prieto-Avalos G, Sánchez-Cervantes JL. Early identification of risk factors in non-alcoholic fatty liver disease (NAFLD) using machine learning. Mathematics. 2023 Jul 7;11(13):3026.
• Suárez M, Martínez R, Torres AM, Torres B, Mateo J. A Machine Learning Method to Identify the Risk Factors for Liver Fibrosis Progression in Nonalcoholic Steatohepatitis. Digestive Diseases and Sciences. 2023 Sep;68(9):3801-9. [1007/s10620-023-08031-y ] [PMID]
• Gheorghe EC, Nicolau C, Kamal A, Udristoiu A, Gruionu L, Saftoiu A. Artificial Intelligence (AI)-Enhanced Ultrasound Techniques Used in Non-Alcoholic Fatty Liver Disease: Are They Ready for Prime Time?. Applied Sciences. 2023 Apr 19;13(8):5080.
• Acharya UR, Fujita H, Sudarshan VK, Mookiah MR, Koh JE, Tan JH, Hagiwara Y, Chua CK, Junnarkar SP, Vijayananthan A, Ng KH. An integrated index for identification of fatty liver disease using radon transform and discrete cosine transform features in ultrasound images. Information Fusion. 2016 Sep 1;31:43-53.
• Zhu Y, Zhang H, Jiang P, Xie C, Luo Y, Chen J. Transcriptional and epigenetic alterations in the progression of non-alcoholic fatty liver disease and biomarkers helping to diagnose non-alcoholic steatohepatitis. Biomedicines. 2023 Mar 21;11(3):970. [3390/biomedicines11030970 ] [PMID]
• Naderi Yaghoti, Amir Reza, Shalbaf, Maghsoudi. Automatic classification of liver fat using tissue features from ultrasound images. Journal of the Faculty of Medicine, Tehran University of Medical Sciences. 2021 Apr 10;79(1):10-7.
• Ma H, Xu CF, Shen Z, Yu CH, Li YM. Application of machine learning techniques for clinical predictive modeling: a cross‐sectional study on nonalcoholic fatty liver disease in China. BioMed research international. 2018;2018(1):4304376. [1155/2018/4304376 ] [PMID]
• Acharya UR, Fujita H, Bhat S, Raghavendra U, Gudigar A, Molinari F, Vijayananthan A, Ng KH. Decision support system for fatty liver disease using GIST descriptors extracted from ultrasound images. Information Fusion. 2016 May 1;29:32-9.
• Birjandi M, Ayatollahi SM, Pourahmad S, Safarpour AR. Prediction and diagnosis of non-alcoholic fatty liver disease (NAFLD) and identification of its associated factors using the classification tree method. Iranian Red Crescent Medical Journal. 2016 Aug 9;18(11):e32858. [5812/ircmj.32858 ] [PMID]
• Wu Y, Yang X, Morris HL, Gurka MJ, Shenkman EA, Cusi K, Bril F, Donahoo WT. Noninvasive diagnosis of nonalcoholic steatohepatitis and advanced liver fibrosis using machine learning methods: Comparative study with existing quantitative risk scores. JMIR Medical Informatics. 2022 Jun 6;10(6):e36997. [2196/36997 ] [PMID]
• Nanyue W, Youhua Y, Dawei H, Bin X, Jia L, Tongda L, Liyuan X, Zengyu S, Yanping C, Jia W. Pulse diagnosis signals analysis of fatty liver disease and cirrhosis patients by using machine learning. The Scientific World Journal. 2015;2015(1):859192. [1155/2015/859192 ] [PMID]
• Chen YS, Chen D, Shen C, Chen M, Jin CH, Xu CF, Yu CH, Li YM. A novel model for predicting fatty liver disease by means of an artificial neural network. Gastroenterology report. 2021 Jan 1;9(1):31-7.[ 1093/gastro/goaa035 ] [PMID]
• Rajathi GI, Jiji GW. Chronic liver disease classification using hybrid whale optimization with simulated annealing and ensemble classifier. Symmetry. 2019 Jan 2;11(1):33.
• Razmpour F, Daryabeygi-Khotbehsara R, Soleimani D, Asgharnezhad H, Shamsi A, Bajestani GS, Nematy M, Pour MR, Maddison R, Islam SM. Application of machine learning in predicting non-alcoholic fatty liver disease using anthropometric and body composition indices. Scientific reports. 2023 Mar 27;13(1):4942. [1038/s41598-023-32129-y ] [PMID]
• Vandel J, Dubois‐Chevalier J, Gheeraert C, Derudas B, Raverdy V, Thuillier D, Gaal L, Francque S, Pattou F, Staels B, Eeckhoute J. Hepatic molecular signatures highlight the sexual dimorphism of nonalcoholic steatohepatitis (NASH). Hepatology. 2021 Mar;73(3):920-36. [1002/hep.31312 ] [PMID]
• Guo X, Wang F, Teodoro G, Farris AB, Kong J. Liver steatosis segmentation with deep learning methods. In2019 IEEE 16th International Symposium on Biomedical Imaging (ISBI 2019) 2019 Apr 8 (pp. 24-27). IEEE. [1109/isbi.2019.8759600 ] [PMID]
• Kalyan K, Jakhia B, Lele RD, Joshi M, Chowdhary A. Artificial neural network application in the diagnosis of disease conditions with liver ultrasound images. Advances in bioinformatics. 2014;2014(1):708279. [1155/2014/708279 ] [PMID]
• Yasar O, Long P, Harder B, Marshall H, Bhasin S, Lee S, Delegge M, Roy S, Doyle O, Leavitt N, Rigg J. Machine learning using longitudinal prescription and medical claims for the detection of non-alcoholic steatohepatitis (NASH). BMJ Health & Care Informatics. 2022 Mar 30;29(1):e100510. [1136/bmjhci-2021-100510 ] [PMID]
• Acharya UR, Sree SV, Ribeiro R, Krishnamurthi G, Marinho RT, Sanches J, Suri JS. Data mining framework for fatty liver disease classification in ultrasound: a hybrid feature extraction paradigm. Medical physics. 2012 Jul;39(7Part1):4255-64. [1118/1.4725759 ] [PMID]
• Perakakis N, Polyzos SA, Yazdani A, Sala-Vila A, Kountouras J, Anastasilakis AD, Mantzoros CS. Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: a proof of concept study. Metabolism. 2019 Dec 1;101:154005. [1016/j.metabol.2019.154005 ] [PMID]
• Mihailescu DM, Gui V, Toma CI, Popescu A, Sporea I. Computer aided diagnosis method for steatosis rating in ultrasound images using random forests. Medical Ultrasonography. 2013 Sep 1;15(3):184-90. [11152/mu.2013.2066.153.dmm1vg2 ] [PMID]
• Wang L, He W, Wang X, Wang J, Wei X, Wu D, Wu Y. Potential diagnostic markers shared between non-alcoholic fatty liver disease and atherosclerosis determined by machine learning and bioinformatic analysis. Frontiers in Medicine. 2024 Mar 28;11:1322102. [3389/fmed.2024.1322102 ] [PMID]
• Atabaki-Pasdar N, Ohlsson M, Viñuela A, Frau F, Pomares-Millan H, Haid M, Jones AG, Thomas EL, Koivula RW, Kurbasic A, Mutie PM. Predicting and elucidating the etiology of fatty liver disease: A machine learning modeling and validation study in the IMI DIRECT cohorts. PLoS medicine. 2020 Jun 19;17(6):e1003149. [1371/journal.pmed.1003149 ] [PMID]
• Qin S, Hou X, Wen Y, Wang C, Tan X, Tian H, Ao Q, Li J, Chu S. Machine learning classifiers for screening nonalcoholic fatty liver disease in general adults. Scientific Reports. 2023 Mar 3;13(1):3638. [1038/s41598-023-30750-5 ] [PMID]
• Yip TF, Ma AJ, Wong VS, Tse YK, Chan HY, Yuen PC, Wong GH. Laboratory parameter‐based machine learning model for excluding non‐alcoholic fatty liver disease (NAFLD) in the general population. Alimentary pharmacology & therapeutics. 2017 Aug;46(4):447-56. [1111/apt.14172 ] [PMID]
• Canbay A, Kälsch J, Neumann U, Rau M, Hohenester S, Baba HA, Rust C, Geier A, Heider D, Sowa JP. Non-invasive assessment of NAFLD as systemic disease—a machine learning perspective. PloS one. 2019 Mar 26;14(3):e0214436. [1371/journal.pone.0214436 ] [PMID]
• \Cheng CT, Cai J, Teng W, Zheng Y, Huang YT, Wang YC, Peng CW, Tang Y, Lee WC, Yeh TS, Xiao J. A flexible three‐dimensional heterophase computed tomography hepatocellular carcinoma detection algorithm for generalizable and practical screening. Hepatology Communications. 2022 Oct;6(10):2901-13. [1002/hep4.2029 ] [PMID]
• Zhang P, Huang H, Xiong Q, He X, Liu Y. Feature analysis and automatic classification of B-mode ultrasound images of fatty liver. Biomedical Signal Processing and Control. 2023 Jan 1;79:104073.
• Zhang D, Zhang X, Lan Y, Wang G. Fatty Liver Recognition Based on Computer Vision. Journal of Applied Sciences. 2013 Dec;13(14):2730-4.
• Wen H, Zheng W, Li M, Li Q, Liu Q, Zhou J, Liu Z, Chen X. Multiparametric quantitative US examination of liver fibrosis: a feature-engineering and machine-learning based analysis. IEEE Journal of Biomedical and Health Informatics. 2021 Jul 30;26(2):715-26. [1109/JBHI.2021.3100319 ] [PMID]
• Goldman O, Ben-Assuli O, Rogowski O, Zeltser D, Shapira I, Berliner S, Zelber-Sagi S, Shenhar-Tsarfaty S. Non-alcoholic fatty liver and liver fibrosis predictive analytics: risk prediction and machine learning techniques for improved preventive medicine. Journal of Medical Systems. 2021 Feb;45:1-2.
• [1007/s10916-020-01693-5 ] [PMID]Pournik O, Dorri S, Zabolinezhad H, Alavian SM, Eslami S. A diagnostic model for cirrhosis in patients with non-alcoholic fatty liver disease: an artificial neural network approach. Medical journal of the Islamic Republic of Iran. 2014 Oct 21;28:116. [PMID]
• Karagoz MA, Akay B, Basturk A, Karaboga D, Nalbantoglu OUJNC, Applications. An unsupervised transfer learning model based on convolutional auto encoder for non-alcoholic steatohepatitis activity scoring and fibrosis staging of liver histopathological images. 2023;35(14):10605-19.
• Suárez M, Martínez R, Torres AM, Ramón A, Blasco P, Mateo J. Personalized risk assessment of hepatic fibrosis after cholecystectomy in metabolic-associated steatotic liver disease: a machine learning approach. Journal of Clinical Medicine. 2023 Oct 12;12(20):6489. [3390/jcm12206489 ] [PMID]
• Dai L, Yuan W, Jiang R, Zhan Z, Zhang L, Xu X, Qian Y, Yang W, Zhang Z. Machine learning-based integration identifies the ferroptosis hub genes in nonalcoholic steatohepatitis. Lipids in Health and Disease. 2024 Jan 23;23(1):23. [1186/s12944-023-01988-9 ] [PMID]
• Tahmasebi A, Wang S, Wessner CE, Vu T, Liu JB, Forsberg F, Civan J, Guglielmo FF, Eisenbrey JR. Ultrasound‐based machine learning approach for detection of nonalcoholic fatty liver disease. Journal of Ultrasound in Medicine. 2023 Aug;42(8):1747-56. [1002/jum.16194 ] [PMID]
• Perveen S, Shahbaz M, Keshavjee K, Guergachi A. A systematic machine learning based approach for the diagnosis of non-alcoholic fatty liver disease risk and progression. Scientific reports. 2018 Feb 1;8(1):2112. [1038/s41598-018-20166-x ] [PMID]
• Liu Q, Liu Z, Xu W, Wen H, Dai M, Chen X. Diagnosis of significant liver fibrosis by using a DCNN model with fusion of features from US B-mode image and Nakagami parametric map: an animal study. IEEE Access. 2021 Mar 9;9:89300-10.
• Qu HQ, Li Q, Grove ML, Lu Y, Pan JJ, Rentfro AR, Bickel PE, Fallon MB, Hanis CL, Boerwinkle E, McCormick JB. Population-based risk factors for elevated alanine aminotransferase in a South Texas Mexican–American population. Archives of medical research. 2012 Aug 1;43(6):482-8. [1016/j.arcmed.2012.08.005 ] [PMID]
• Chou TH, Yeh HJ, Chang CC, Tang JH, Kao WY, Su IC, Li CH, Chang WH, Huang CK, Sufriyana H, Su EC. Deep learning for abdominal ultrasound: A computer-aided diagnostic system for the severity of fatty liver. Journal of the Chinese Medical Association. 2021 Sep 1;84(9):842-50. [1097/JCMA.0000000000000585 ] [PMID]
• Li J, Yang D, Chen T, Li T, Jiang P, Zheng X, Jiang F. Nine Markers to Predict Nonalcoholic Fatty Liver Disease for a Chinese Diabetic Population. Journal of Medical Imaging and Health Informatics. 2021 Mar 1;11(3):730-5.
• Podder S, Mallick A, Das S, Sau K, Roy A. Accurate diagnosis of liver diseases through the application of deep convolutional neural network on biopsy images. AIMS Biophysics. 2023 Oct 1;10(4).
• Rhyou SY, Yoo JC. Cascaded deep learning neural network for automated liver steatosis diagnosis using ultrasound images. Sensors. 2021 Aug 5;21(16):5304. [3390/s21165304 ] [PMID]
• Wang C, Yan J, Zhang S, Xie Y, Nie Y, Chen Z, Xu S. Screening new blood indicators for Non-alcoholic Fatty Liver Disease (NAFLD) diagnosis of Chinese based on machine learning. Frontiers in Medicine. 2022 Jun 9;9:771219. [3389/fmed.2022.771219 ] [PMID]
• Chen YY, Lin CY, Yen HH, Su PY, Zeng YH, Huang SP, Liu IL. Machine-learning algorithm for predicting fatty liver disease in a Taiwanese population. Journal of Personalized Medicine. 2022 Jun 23;12(7):1026. [3390/jpm12071026 ] [PMID]
• Byra M, Styczynski G, Szmigielski C, Kalinowski P, Michałowski Ł, Paluszkiewicz R, Ziarkiewicz-Wróblewska B, Zieniewicz K, Sobieraj P, Nowicki A. Transfer learning with deep convolutional neural network for liver steatosis assessment in ultrasound images. International journal of computer assisted radiology and surgery. 2018 Dec;13:1895-903. [1007/s11548-018-1843-2 ] [PMID]
• Mamandipoor B, Wernly S, Semmler G, Flamm M, Jung C, Aigner E, Datz C, Wernly B, Osmani V. Machine learning models predict liver steatosis but not liver fibrosis in a prospective cohort study. Clinics and research in hepatology and gastroenterology. 2023 Aug 1;47(7):102181. [1016/j.clinre.2023.102181 ] [PMID]
• Renukadevi T, Karunakaran S. Optimizing deep belief network parameters using grasshopper algorithm for liver disease classification. International Journal of Imaging Systems and Technology. 2020 Mar;30(1):168-84.
• Flores YN, Amoon AT, Su B, Velazquez-Cruz R, Ramírez-Palacios P, Salmerón J, Rivera-Paredez B, Sinsheimer JS, Lusis AJ, Huertas-Vazquez A, Saab S. Serum lipids are associated with nonalcoholic fatty liver disease: a pilot case-control study in Mexico. Lipids in health and disease. 2021 Dec;20:1-7. [1186/s12944-021-01526-5 ] [PMID]
• Naderi Yaghouti AR, Zamanian H, Shalbaf A. Machine learning approaches for early detection of non-alcoholic steatohepatitis based on clinical and blood parameters. Scientific Reports. 2024 Jan 30;14(1):2442. [1038/s41598-024-51741-0 ] [PMID]
• Constantinescu EC, Udriștoiu AL, Udriștoiu ȘC, Iacob AV, Gruionu LG, Gruionu G, Săndulescu L, Săftoiu A. Transfer learning with pre-trained deep convolutional neural networks for the automatic assessment of liver steatosis in ultrasound images. Medical Ultrasonography. 2021 May 20;23(2):135-9. [11152/mu-2746 ] [PMID]
• Sim KC, Kim MJ, Cho Y, Kim HJ, Park BJ, Sung DJ, Han NY, Han YE, Kim TH, Lee YJ. Radiomics analysis of magnetic resonance proton density fat fraction for the diagnosis of hepatic steatosis in patients with suspected non-alcoholic fatty liver disease. Journal of Korean Medical Science. 2022 Dec 19;37(49). [3346/jkms.2022.37.e339 ] [PMID]
• Che H, Brown LG, Foran DJ, Nosher JL, Hacihaliloglu I. Liver disease classification from ultrasound using multi-scale CNN. International Journal of Computer Assisted Radiology and Surgery. 2021 Sep;16(9):1537-48. [1007/s11548-021-02414-0 ] [PMID]
• Park I, Kim N, Lee S, Park K, Son MY, Cho HS, Kim DS. Characterization of signature trends across the spectrum of non-alcoholic fatty liver disease using deep learning method. Life Sciences. 2023 Feb 1;314:121195. [1016/j.lfs.2022.121195 ] [PMID]
• Sorino P, Caruso MG, Misciagna G, Bonfiglio C, Campanella A, Mirizzi A, Franco I, Bianco A, Buongiorno C, Liuzzi R, Cisternino AM. Selecting the best machine learning algorithm to support the diagnosis of Non-Alcoholic Fatty Liver Disease: A meta learner study. PLoS One. 2020 Oct 20;15(10):e0240867. [1371/journal.pone.0240867 ] [PMID]
• Hwang JH, Kim HJ, Park H, Lee BS, Son HY, Kim YB, Jun SY, Park JH, Lee J, Cho JW. Implementation and practice of deep learning-based instance segmentation algorithm for quantification of hepatic fibrosis at whole slide level in Sprague-Dawley rats. Toxicologic Pathology. 2022 Feb;50(2):186-96. [1177/01926233211057128 ] [PMID]
• Yilmaz Y, Eren F. Identification of a support vector machine-based biomarker panel with high sensitivity and specificity for nonalcoholic steatohepatitis. Clinica Chimica Acta. 2012 Dec 24;414:154-7. [1016/j.cca.2012.08.005 ] [PMID]
• Yen TJ, Yang CT, Lee YJ, Chen CH, Yang HC. Fatty liver classification via risk controlled neural networks trained on grouped ultrasound image data. Scientific Reports. 2024 Mar 28;14(1):7345. [1038/s41598-024-57386-3 ] [PMID]
• Zhang Z, Wang S, Zhu Z, Nie B. Identification of potential feature genes in non-alcoholic fatty liver disease using bioinformatics analysis and machine learning strategies. Computers in biology and medicine. 2023 May 1;157:106724. [1016/j.compbiomed.2023.106724 ] [PMID]
• Sarvestany SS, Kwong JC, Azhie A, Dong V, Cerocchi O, Ali AF, Karnam RS, Kuriry H, Shengir M, Candido E, Duchen R. Development and validation of an ensemble machine learning framework for detection of all-cause advanced hepatic fibrosis: a retrospective cohort study. The Lancet Digital Health. 2022 Mar 1;4(3):e188-99. [1016/S2589-7500(21)00270-3 ] [PMID]
• Banihashem SY, Shishehchi S. Ontology-Based decision tree model for prediction of fatty liver diseases. Computer Methods in Biomechanics and Biomedical Engineering. 2023 Apr 26;26(6):639-49. [1080/10255842.2022.2081502 ] [PMID]
• Deng Y, Ma Y, Fu J, Wang X, Yu C, Lv J, Man S, Wang B, Li L. A dynamic machine learning model for prediction of NAFLD in a health checkup population: A longitudinal study. Heliyon. 2023 Aug 1;9(8). [1016/j.heliyon.2023.e18758 ] [PMID]
• Pickhardt PJ, Blake GM, Graffy PM, Sandfort V, Elton DC, Perez AA, Summers RM. Liver steatosis categorization on contrast-enhanced CT using a fully automated deep learning volumetric segmentation tool: evaluation in 1204 healthy adults using unenhanced CT as a reference standard. American Journal of Roentgenology. 2021 Aug 16;217(2):359-67. [2214/AJR.20.24415 ] [PMID]
• Oh TG, Kim SM, Caussy C, Fu T, Guo J, Bassirian S, Singh S, Madamba EV, Bettencourt R, Richards L, Ruth TY. A universal gut-microbiome-derived signature predicts cirrhosis. Cell metabolism. 2020 Nov 3;32(5):878-88. [1016/j.cmet.2020.06.005 ] [PMID]
• Weng S, Hu D, Chen J, Yang Y, Peng D. Prediction of fatty liver disease in a Chinese population using machine-learning algorithms. Diagnostics. 2023 Mar 18;13(6):1168. [3390/diagnostics13061168 ] [PMID]
• Han A, Byra M, Heba E, Andre MP, Erdman Jr JW, Loomba R, Sirlin CB, O’Brien Jr WD. Noninvasive diagnosis of nonalcoholic fatty liver disease and quantification of liver fat with radiofrequency ultrasound data using one-dimensional convolutional neural networks. Radiology. 2020 May;295(2):342-50. [1148/radiol.2020191160 ] [PMID]
• Jiang H, Hu Y, Zhang Z, Chen X, Gao JJLiH, Disease. Identification of metabolic biomarkers associated with nonalcoholic fatty liver disease. 2023;22(1):150. [1186/s12944-023-01911-2 ] [PMID]
• Okanoue T, Shima T, Mitsumoto Y, Umemura A, Yamaguchi K, Itoh Y, Yoneda M, Nakajima A, Mizukoshi E, Kaneko S, Harada K. Artificial intelligence/neural network system for the screening of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology Research. 2021 May;51(5):554-69. [1111/hepr.13628 ] [PMID]
• Sowa JP, Atmaca Ö, Kahraman A, Schlattjan M, Lindner M, Sydor S, Scherbaum N, Lackner K, Gerken G, Heider D, Arteel GE. Non-invasive separation of alcoholic and non-alcoholic liver disease with predictive modeling. PLoS One. 2014 Jul 2;9(7):e101444. [1371/journal.pone.0101444 ] [PMID]
• Acharya UR, Faust O, Molinari F, Sree SV, Junnarkar SP, Sudarshan V. Ultrasound-based tissue characterization and classification of fatty liver disease: A screening and diagnostic paradigm. Knowledge-Based Systems. 2015 Feb 1;75:66-77.
• Peng HY, Duan SJ, Pan L, Wang MY, Chen JL, Wang YC, Yao SK. Development and validation of machine learning models for nonalcoholic fatty liver disease. Hepatobiliary & Pancreatic Diseases International. 2023 Dec 1;22(6):615-21. [1016/j.hbpd.2023.03.009 ] [PMID]
• Liu Z, Wen H, Zhu Z, Li Q, Liu L, Li T, Xu W, Hou C, Huang B, Li Z, Dong C. Diagnosis of significant liver fibrosis in patients with chronic hepatitis B using a deep learning-based data integration network. Hepatology International. 2022 Jun;16(3):526-36. [1007/s12072-021-10294-4 ] [PMID]
• Özdil A, Yilmaz B. Medical infrared thermal image based fatty liver classification using machine and deep learning. Quantitative InfraRed Thermography Journal. 2024 Mar 14;21(2):102-19.
• Byra M, Han A, Boehringer AS, Zhang YN, O'Brien Jr WD, Erdman Jr JW, Loomba R, Sirlin CB, Andre M. Liver fat assessment in multiview sonography using transfer learning with convolutional neural networks. Journal of Ultrasound in Medicine. 2022 Jan;41(1):175-84. [1002/jum.15693 ] [PMID]
• Li G, Luo Y, Deng W, Xu X, Liu A, Song E. Computer aided diagnosis of fatty liver ultrasonic images based on support vector machine. In2008 30th Annual International Conference of the IEEE Engineering in Medicine and Biology Society 2008 Aug 20 (pp. 4768-4771). IEEE. [1109/IEMBS.2008.4650279 ] [PMID]
• Rui F, Yeo YH, Xu L, Zheng Q, Xu X, Ni W, Tan Y, Zeng QL, He Z, Tian X, Xue Q. Development of a machine learning-based model to predict hepatic inflammation in chronic hepatitis B patients with concurrent hepatic steatosis: a cohort study. EClinicalMedicine. 2024 Feb 1;68. [1016/j.eclinm.2023.102419 ] [PMID]
• Xing Y, Zhang P, Li X, Jin S, Xu M, Jia J, Wang HJ, Li L, Wang H. New predictive models and indices for screening MAFLD in school-aged overweight/obese children. European Journal of Pediatrics. 2023 Nov;182(11):5025-36. [1007/s00431-023-05175-x ] [PMID]
• Zhu H, Liu Y, Gao X, Zhang L. Combined CNN and pixel feature image for fatty liver ultrasound image classification. Computational and Mathematical Methods in Medicine. 2022;2022(1):9385734.
• Dai S, Guo X, Liu S, Tu L, Hu X, Cui J, Ruan Q, Tan X, Lu H, Jiang T, Xu J. Application of intelligent tongue image analysis in conjunction with microbiomes in the diagnosis of MAFLD. Heliyon. 2024 Apr 15;10(7). [1016/j.heliyon.2024.e29269 ] [PMID]
• Cao W, An X, Cong L, Lyu C, Zhou Q, Guo R. Application of deep learning in quantitative analysis of 2‐dimensional ultrasound imaging of nonalcoholic fatty liver disease. Journal of Ultrasound in Medicine. 2020 Jan;39(1):51-9. [1002/jum.15070 ] [PMID]
• Lin RH, Chuang CL. A hybrid diagnosis model for determining the types of the liver disease. Computers in Biology and Medicine. 2010 Jul 1;40(7):665-70. [1016/j.compbiomed.2010.06.002 ] [PMID]
• Listopad S, Magnan C, Asghar A, Stolz A, Tayek JA, Liu ZX, Morgan TR, Norden-Krichmar TM. Differentiating between liver diseases by applying multiclass machine learning approaches to transcriptomics of liver tissue or blood-based samples. JHEP Reports. 2022 Oct 1;4(10):100560. [1016/j.jhepr.2022.100560 ] [PMID]
• Khusial RD, Cioffi CE, Caltharp SA, Krasinskas AM, Alazraki A, Knight‐Scott J, Cleeton R, Castillo‐Leon E, Jones DP, Pierpont B, Caprio S. Development of a plasma screening panel for pediatric nonalcoholic fatty liver disease using metabolomics. Hepatology communications. 2019 Oct;3(10):1311-21. [1002/hep4.1417 ] [PMID]
• Acharya UR, Koh JE, Hagiwara Y, Tan JH, Gertych A, Vijayananthan A, Yaakup NA, Abdullah BJ, Fabell MK, Yeong CH. Automated diagnosis of focal liver lesions using bidirectional empirical mode decomposition features. Computers in biology and medicine. 2018 Mar 1;94:11-8. [1016/j.compbiomed.2017.12.024 ] [PMID]
• Qu H, Minacapelli CD, Tait C, Gupta K, Bhurwal A, Catalano C, Dafalla R, Metaxas D, Rustgi VK. Training of computational algorithms to predict NAFLD activity score and fibrosis stage from liver histopathology slides. Computer Methods and Programs in Biomedicine. 2021 Aug 1;207:106153. [1016/j.cmpb.2021.106153 ] [PMID]
• Chen W, Zhang Y, Wu W, Yang H, Huang W. Machine learning-based predictive model for abdominal diseases using physical examination datasets. Computers in Biology and Medicine. 2024 May 1;173:108249. [1016/j.compbiomed.2024.108249 ] [PMID]
• Liu YX, Liu X, Cen C, Li X, Liu JM, Ming ZY, Yu SF, Tang XF, Zhou L, Yu J, Huang KJ. Comparison and development of advanced machine learning tools to predict nonalcoholic fatty liver disease: An extended study. Hepatobiliary & Pancreatic Diseases International. 2021 Oct 1;20(5):409-15. [1016/j.hbpd.2021.08.004 ] [PMID]
• Rehman MU, Najam S, Khalid S, Shafique A, Alqahtani F, Baothman F, Shah SY, Abbasi QH, Imran MA, Ahmad J. Notice of Retraction: Infrared Sensing Based Non-Invasive Initial Diagnosis of Chronic Liver Disease Using Ensemble Learning. IEEE Sensors Journal. 2021 Jun 22;21(17):19395-406.
• Wu CC, Yeh WC, Hsu WD, Islam MM, Nguyen PA, Poly TN, Wang YC, Yang HC, Li YC. Prediction of fatty liver disease using machine learning algorithms. Computer methods and programs in biomedicine. 2019 Mar 1;170:23-9. [1016/j.cmpb.2018.12.032 ] [PMID]
• Li B, Tai DI, Yan K, Chen YC, Chen CJ, Huang SF, Hsu TH, Yu WT, Xiao J, Le L, Harrison AP. Accurate and generalizable quantitative scoring of liver steatosis from ultrasound images via scalable deep learning. World Journal of Gastroenterology. 2022 Jun 14;28(22):2494. [3748/wjg.v28.i22.2494 ] [PMID]
• Wen W, Wu P, Zhang Y, Chen Z, Sun J, Chen H. Comprehensive analysis of NAFLD and the therapeutic target identified. Frontiers in cell and developmental biology. 2021 Sep 20;9:704704. [3389/fcell.2021.704704] [PMID]
• Vianna P, Calce SI, Boustros P, Larocque-Rigney C, Patry-Beaudoin L, Luo YH, Aslan E, Marinos J, Alamri TM, Vu KN, Murphy-Lavallée J. Comparison of radiologists and deep learning for US grading of hepatic steatosis. Radiology. 2023 Oct 3;309(1):e230659. [1148/radiol.230659 ] [PMID]
• Guo Z, Yu X, Fang Z, Yang K, Liu C, Dong Z, Liu C. The role of endoplasmic reticulum stress-related genes in the diagnosis and subtyping of non-alcoholic fatty liver disease. General Physiology & Biophysics. 2024 Mar 1;43(2). [4149/gpb_2023042 ] [PMID]
• Sim KC, Kim MJ, Cho Y, Kim HJ, Park BJ, Sung DJ, Han YE, Han NY, Kim TH, Lee YJ. Diagnostic feasibility of magnetic resonance elastography radiomics analysis for the assessment of hepatic fibrosis in patients with nonalcoholic fatty liver disease. Journal of Computer Assisted Tomography. 2022 Jul 1;46(4):505-13. [1097/RCT.0000000000001308 ] [PMID]
• Lee LW, Yen JB, Lu HK, Liao YS. Prediction of nonalcoholic fatty liver disease by anthropometric indices and bioelectrical impedance analysis in children. Childhood Obesity. 2021 Dec 1;17(8):551-8. [1089/chi.2021.0054 ] [PMID]

[165]Khan H, Srivastav A, Mishra AK, editors. Use of Classification Algorithms in Health Care2020.[ 10.1108/978-1-83909-099-820201007]

[166]An Q, Rahman S, Zhou J, Kang JJ. A Comprehensive Review on Machine Learning in Healthcare Industry: Classification, Restrictions, Opportunities and Challenges. Sensors (Basel). 2023;23(9):4178.[ 10.3390/s23094178][PMID]

[167]Mahesh BJIJoS, . R. Machine learning algorithms-a review. 2020;9(1):381-6[10.21275/ART20203995]

[168]Zemmal N, Azizi N, Sellami M, Zenakhra D, Cheriguene S, Dey N, et al. Robust feature selection algorithm based on transductive SVM wrapper and genetic algorithm: application on computer-aided glaucoma classification. 2018;17:310-46[10.1504/IJISTA.2018.094018]

[169]Tariq M, Al-Khasawneh MA, Irtaza G, Fiaz MW, Safi W, Asif RJICoBAfT, et al. Intelligent System to Diagnosis of Pneumonia in Children using Support Vector Machine. 2023:1-6[10.1109/ICBATS57792.2023.10111167]

[170]Wulandari RI, Fa’rifah RY, Utama NIJICoDS, Applications I. Application of the Random Forest Algorithm for Breast Cancer Analysis with Data Balancing: Case Study at Al-Ihsan Hospital. 2024:254-9[10.1109/ICoDSA62899.2024.10651924]

[171]Blotwijk S, Raets C, Barbé KJIISoMM, Applications. Exploratory study on Evolutionary Random Forests for Classification in Medical Datasets. 2023:1-6[10.1109/MeMeA57477.2023.10171908]

[172]Meenakshi TJWPC. Automatic Detection of Diseases in Leaves of Medicinal Plants Using Modified Logistic Regression Algorithm. 2023;131:2573 - 97[10.1007/s11277-023-10555-5]

[173]Liu LJICoR, System I. Research on Logistic Regression Algorithm of Breast Cancer Diagnose Data by Machine Learning. 2018:157-60[10.1109/ICRIS.2018.00049]

[174]        Randhawan B, Jagtap R, Bhilawade A, Chaure DJIJfRiAS, Technology E. Heart Disease Prediction Using Logistic Regression Algorithm. 2022[10.1088/1757-899X/1022/1/012072]

[175]Magrabi F, Ammenwerth E, McNair JB, De Keizer NF, Hypponen H, Nykanen P, et al. Artificial Intelligence in Clinical Decision Support: Challenges for Evaluating AI and Practical Implications. Yearb Med Inform. 2019;28(1):128-34.[10.1055/s-0039-1677903][PMID]

[176]Durosini I, Pizzoli SFM, Strika M, Pravettoni G. Artificial intelligence and medicine: A psychological perspective on AI implementation in healthcare context.  Artificial Intelligence for Medicine: Elsevier; 2024. p. 231-7.[ 10.1016/B978-0-443-13671-9.00011-9]

[177]Ryan DK, Maclean RH, Balston A, Scourfield A, Shah AD, Ross J. Artificial intelligence and machine learning for clinical pharmacology. Br J Clin Pharmacol. 2024;90(3):629-39.[ 10.1111/bcp.15930][PMID]

[178]Lainjo BJJoAI. Original Research Article A meta-study on optimizing healthcare performance with artificial intelligence and machine learning. 2024;7(5) [10.32629/jai.v7i5.1535]

[179]Handelman GS, Kok HK, Chandra RV, Razavi AH, Huang S, Brooks M, et al. Peering into the black box of artificial intelligence: evaluation metrics of machine learning methods. 2019;212(1):38-43[10.2214/ajr.18.20224 ][PMID]

[180]Martha S, Warangal T, Priya IMN. ROLE OF STATISTICS IN ARTIFICIAL INTELLIGENCE.

[181]Decharatanachart P, Chaiteerakij R, Tiyarattanachai T, Treeprasertsuk S. Application of artificial intelligence in non-alcoholic fatty liver disease and liver fibrosis: a systematic review and meta-analysis. Therap Adv Gastroenterol. 2021;14:17562848211062807.[ 10.1177/17562848211062807] [PMID]

[182]Mishra S, Tandon DRJIJOSRIE, MANAGEMENT. Federated Learning in Healthcare: A Path Towards Decentralized and Secure Medical Insights. 2024[10.1109/JIOT.2023.3329061]

[183]Tiwari RJIJOSRIE, MANAGEMENT. The Use of AI and Machine Learning in Healthcare and its Potential to Improve Patient Outcomes. 2023

[184]Johnson KW, Torres Soto J, Glicksberg BS, Shameer K, Miotto R, Ali M, et al. Artificial Intelligence in Cardiology. J Am Coll Cardiol.2018;71(23):2668-79. [10.1016/j.jacc.2018.03.521] [PMID]

[185]Aung YYM, Wong DCS, Ting DSW. The promise of artificial intelligence: a review of the opportunities and challenges of artificial intelligence in healthcare. Br Med Bull. 2021;139(1):4-15.[10.1093/bmb/ldab016] [PMID]

[186]Familoni BTJIJoFiB, Research P. Ethical frameworks for AI in healthcare entrepreneurship: A theoretical examination of challenges and approaches. 2024